Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sure Genomics was a private U.S. personal genomics company that sought to offer direct-to-consumer whole-genome sequencing, storage, and interpretation services. Its offering centered on the SureDNA saliva-based sequencing service, with genomic data stored in the company's HIPAA-compliant SureVault system and interpreted through an interactive software interface. The company positioned itself as a consumer health platform spanning disease-risk reporting, drug-response insights, wellness, traits, and ancestry. Public reporting indicates the business launched commercially around 2016 but later became inactive/deadpooled, and its domain is no longer operating as an active company website.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sure Genomics.